WHO said Omicron may spread more quickly than other forms, and preliminary evidence suggested there is an increased risk of reinfection
WHO has classified the B.1.1.529 variant detected in South Africa as a 'variant of concern', saying it may spread more quickly than other forms of the virus
WHO is convening an emergency meeting Friday to discuss the potentially rapidly spreading COVID strain found in South Africa and Botswana
The UN agency extended travel restrictions on the South Asian country by three months due to it being listed among the last polio-endemic countries
WHO Europe called on people to get vaccinated and respect proper hygiene and practice social distancing to help stop the spread of the virus
The unequal distribution of Covid-19 boosters in rich countries, as many poor countries struggle to get even their first shots is a "scandal" that must end, WHO chief said
Vladimir Putin called on the WHO to accelerate the recognition of new Covid-19 vaccines, adding that the accessibility to doses in developing countries is low due to unfair compassion
Indian cities' air pollution was even higher than the WHO set standards and worse than most cities even on the days pollution was at its lowest
UK government said India's Covaxin will be added to its list of approved COVID-19 vaccines for international travellers from November 22
The last-minute addition comes less than one week before the US launches its new travel system, granting entry to travellers who have received a vaccine that has been approved by the FDA or WHO.
Move will ease international travel for those vaccinated with the jab
Three Lok Sabha and 29 Assembly constituencies held by-elections on October 30.
Country can produce more than 5 billion doses for the world next year to contain the coronavirus, he says.
WHO officials have pointed to a number of factors including relatively low rates of vaccination in some countries in eastern Europe
WHO said it expects to receive clarifications from Bharat Biotech by the end of this week on its Covaxin -- and will meet on November 3 for a final risk-benefit assessment for Emergency Use Listing
A technical advisory group of the WHO reviewing data on Covaxin for the emergency use listing of India's vaccine and if it is satisfied a recommendation is expected within the next 24 hours or so
WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya. Had a call with @mansukhmandviya, India's Health Minister, to discuss #India's ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India's support to strengthen WHO, incl. via flexible, sustainable financing, Ghebreyesus tweeted on Tuesday. The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and license sharing through C-TAP. COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating ...
India also reported a 13 per cent decline in the number of deaths during the week of October 11 to 17, the WHO has said
Industry insiders say typically a WHO EUL takes between two months and a year
The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week